|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | G01N 33/6869 | (2013.01) |
| C12Q 1/6883 | (2018.01) | ||
| G01N 33/68 | (2006.01) | ||
| C12Q2600/156 | (2013.01) | ||
| A61P 11/06 | (2006.01) | ||
| C12Q2600/158 | (2013.01) | ||
| C12Q 1/6883 | (2013.01) | ||
| A61P 1/04 | (2018.01) | ||
| A61P 1/16 | (2018.01) | ||
| A61P 11/00 | (2018.01) | ||
| A61P 11/02 | (2018.01) | ||
| A61P 11/06 | (2018.01) | ||
| A61P 17/00 | (2018.01) | ||
| A61P 17/06 | (2018.01) | ||
| A61P 19/02 | (2018.01) | ||
| A61P 25/00 | (2018.01) | ||
| A61P 25/04 | (2018.01) | ||
| A61P 25/28 | (2018.01) | ||
| A61P 27/02 | (2018.01) | ||
| A61P 29/00 | (2018.01) | ||
| A61P 31/00 | (2018.01) | ||
| A61P 31/04 | (2018.01) | ||
| A61P 31/12 | (2018.01) | ||
| A61P 31/16 | (2018.01) | ||
| A61P 33/00 | (2018.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 37/02 | (2018.01) | ||
| A61P 37/08 | (2018.01) | ||
| A61P 43/00 | (2018.01) | ||
| A61P 7/00 | (2018.01) | ||
| A61P 3/10 | (2018.01) |
| (11) | Number of the document | 3218515 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15802254.1 |
| Date of filing the European patent application | 2015-11-10 | |
| (97) | Date of publication of the European application | 2017-09-20 |
| (45) | Date of publication and mention of the grant of the patent | 2023-04-26 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/059982 |
| Date | 2015-11-10 |
| (87) | Number | WO 2016/077366 |
| Date | 2016-05-19 |
| (30) | Number | Date | Country code |
| 201462077854 P | 2014-11-10 | US | |
| 201562165703 P | 2015-05-22 | US |
| (72) |
KHOSLA, Rajita , US
RAMIREZ-CARROZZI, Vladimir , US
STATON, Tracy , US
YASPAN, Brian , US
ARRON, Joseph , US
CHOY, David , US
DRESSEN, Amy , US
|
| (73) |
F. Hoffmann-La Roche AG ,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (54) | THERAPEUTIC AND DIAGNOSTIC METHODS FOR IL-33-MEDIATED DISORDERS |
| THERAPEUTIC AND DIAGNOSTIC METHODS FOR IL-33-MEDIATED DISORDERS |